Qiming & K2VC Double Down on Immunotherapy
02 Jun 2023
US$ 19.00
Qiming Venture Partners (Qiming) has led and made a follow-on investment in the pre-series A plus funding round of LTZ T...
Related Publications
The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......
Boost Capital, Global Catalyst Partners Japan, Gogin Capital, and Aichi Capital were party to the ¥2 billion (US$14...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.